341 related articles for article (PubMed ID: 33212778)
1. Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature.
Montemurro N; Perrini P; Rapone B
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33212778
[TBL] [Abstract][Full Text] [Related]
2. Type 2 Diabetes Mellitus and Glioblastoma Multiforme-Assessing Risk and Survival: Results of a Large Retrospective Study and Systematic Review of the Literature.
Barami K; Lyon L; Conell C
World Neurosurg; 2017 Oct; 106():300-307. PubMed ID: 28698089
[TBL] [Abstract][Full Text] [Related]
3. The impact of hyperglycemia on survival in glioblastoma: A systematic review and meta-analysis.
Lu VM; Goyal A; Vaughan LS; McDonald KL
Clin Neurol Neurosurg; 2018 Jul; 170():165-169. PubMed ID: 29803727
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients.
Welch MR; Grommes C
CNS Oncol; 2013 May; 2(3):237-46. PubMed ID: 25054464
[TBL] [Abstract][Full Text] [Related]
5. Association Between Perioperative Hyperglycemia and Survival in Patients With Glioblastoma.
Hagan K; Bhavsar S; Arunkumar R; Grasu R; Dang A; Carlson R; Cowles C; Arnold B; Potylchansky Y; Rahlfs TF; Lipski I; Walsh C; Jimenez F; Nguyen AT; Feng L; Cata JP
J Neurosurg Anesthesiol; 2017 Jan; 29(1):21-29. PubMed ID: 27438798
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
Konar SK; Bir SC; Maiti TK; Nanda A
J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
[TBL] [Abstract][Full Text] [Related]
7. Metformin influences progression in diabetic glioblastoma patients.
Adeberg S; Bernhardt D; Ben Harrabi S; Bostel T; Mohr A; Koelsche C; Diehl C; Rieken S; Debus J
Strahlenther Onkol; 2015 Dec; 191(12):928-35. PubMed ID: 26329695
[TBL] [Abstract][Full Text] [Related]
8. Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.
Gerges C; Elder T; Penuela M; Rossetti N; Maynard M; Jeong S; Wright CH; Wright J; Zhou X; Burant C; Sajatovic M; Hodges T
Clin Neurol Neurosurg; 2020 Aug; 195():106054. PubMed ID: 32650210
[TBL] [Abstract][Full Text] [Related]
9. The Association Between Common Clinical Characteristics and Postoperative Morbidity and Overall Survival in Patients with Glioblastoma.
Liu W; Qdaisat A; Yeung J; Lopez G; Weinberg J; Zhou S; Cohen L; Bruera E; Yeung SJ
Oncologist; 2019 Apr; 24(4):529-536. PubMed ID: 30049883
[TBL] [Abstract][Full Text] [Related]
10. Ten-year survival in glioblastoma. A systematic review.
Tykocki T; Eltayeb M
J Clin Neurosci; 2018 Aug; 54():7-13. PubMed ID: 29801989
[TBL] [Abstract][Full Text] [Related]
11. Significant Systemic Insulin Resistance is Associated With Unique Glioblastoma Multiforme Phenotype.
Laviv Y; Sapirstein E; Kanner AA; Berkowitz S; Fichman S; Benouaich-Amiel A; Yust-Katz S; Kasper EE; Siegal T
Clin Pathol; 2023; 16():2632010X231207725. PubMed ID: 37920781
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
13. Effect of marital status on survival in glioblastoma multiforme by demographics, education, economic factors, and insurance status.
Xie JC; Yang S; Liu XY; Zhao YX
Cancer Med; 2018 Aug; 7(8):3722-3742. PubMed ID: 30009575
[TBL] [Abstract][Full Text] [Related]
14. Modifiable risk factors for glioblastoma: a systematic review and meta-analysis.
Yoshikawa MH; Rabelo NN; Telles JPM; Figueiredo EG
Neurosurg Rev; 2023 Jun; 46(1):143. PubMed ID: 37340151
[TBL] [Abstract][Full Text] [Related]
15. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.
Elmaci İ; Altinoz MA
Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
[TBL] [Abstract][Full Text] [Related]
16. Influence of insurance status on survival of adults with glioblastoma multiforme: A population-based study.
Rong X; Yang W; Garzon-Muvdi T; Caplan JM; Hui X; Lim M; Huang J
Cancer; 2016 Oct; 122(20):3157-3165. PubMed ID: 27500668
[TBL] [Abstract][Full Text] [Related]
17. Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: A retrospective, single-center study.
Ryu JY; Min KL; Chang MJ
PLoS One; 2019; 14(12):e0225599. PubMed ID: 31790459
[TBL] [Abstract][Full Text] [Related]
18. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
19. Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review.
Chiang JI; Jani BD; Mair FS; Nicholl BI; Furler J; O'Neal D; Jenkins A; Condron P; Manski-Nankervis JA
PLoS One; 2018; 13(12):e0209585. PubMed ID: 30586451
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma multiforme in patients with human immunodeficiency virus: an integrated review and analysis.
Mendez Valdez MJ; Lu VM; Kim E; Rivas SR; Govindarajan V; Ivan M; Komotar R; Nath A; Heiss JD; Shah AH
J Neurooncol; 2022 Sep; 159(3):571-579. PubMed ID: 35857248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
